久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/05/31 | 3,682 | 3,741 | 3,682 | 3,736 | +74 | +2% | 301,000 |
| 2024/05/30 | 3,650 | 3,666 | 3,600 | 3,662 | -10 | -0.3% | 127,000 |
| 2024/05/29 | 3,700 | 3,710 | 3,665 | 3,672 | -33 | -0.9% | 110,000 |
| 2024/05/28 | 3,711 | 3,738 | 3,705 | 3,705 | -36 | -1% | 85,600 |
| 2024/05/27 | 3,738 | 3,746 | 3,699 | 3,741 | +6 | +0.2% | 119,400 |
| 2024/05/24 | 3,742 | 3,777 | 3,705 | 3,735 | +26 | +0.7% | 205,500 |
| 2024/05/23 | 3,705 | 3,722 | 3,696 | 3,709 | ±0 | ±0% | 103,600 |
| 2024/05/22 | 3,750 | 3,768 | 3,697 | 3,709 | -41 | -1.1% | 160,700 |
| 2024/05/21 | 3,809 | 3,815 | 3,750 | 3,750 | -59 | -1.5% | 147,800 |
| 2024/05/20 | 3,795 | 3,835 | 3,794 | 3,809 | +13 | +0.3% | 86,300 |
| 2024/05/17 | 3,792 | 3,817 | 3,768 | 3,796 | ±0 | ±0% | 93,100 |
| 2024/05/16 | 3,774 | 3,803 | 3,766 | 3,796 | +22 | +0.6% | 132,700 |
| 2024/05/15 | 3,790 | 3,804 | 3,761 | 3,774 | -21 | -0.6% | 79,600 |
| 2024/05/14 | 3,785 | 3,816 | 3,785 | 3,795 | +2 | +0.1% | 65,900 |
| 2024/05/13 | 3,805 | 3,816 | 3,776 | 3,793 | -30 | -0.8% | 81,400 |
| 2024/05/10 | 3,840 | 3,854 | 3,805 | 3,823 | -12 | -0.3% | 120,900 |
| 2024/05/09 | 3,800 | 3,874 | 3,779 | 3,835 | +57 | +1.5% | 187,800 |
| 2024/05/08 | 3,783 | 3,792 | 3,738 | 3,778 | +12 | +0.3% | 134,500 |
| 2024/05/07 | 3,741 | 3,769 | 3,721 | 3,766 | +26 | +0.7% | 212,600 |
| 2024/05/02 | 3,850 | 3,858 | 3,729 | 3,740 | -79 | -2.1% | 323,000 |
| 2024/05/01 | 3,820 | 3,835 | 3,798 | 3,819 | -4 | -0.1% | 143,600 |
| 2024/04/30 | 3,798 | 3,824 | 3,769 | 3,823 | +44 | +1.2% | 111,900 |
| 2024/04/26 | 3,740 | 3,779 | 3,688 | 3,779 | +69 | +1.9% | 224,600 |
| 2024/04/25 | 3,734 | 3,736 | 3,701 | 3,710 | -38 | -1% | 203,900 |
| 2024/04/24 | 3,788 | 3,792 | 3,740 | 3,748 | -32 | -0.8% | 122,000 |
| 2024/04/23 | 3,790 | 3,799 | 3,762 | 3,780 | +6 | +0.2% | 101,800 |
| 2024/04/22 | 3,732 | 3,781 | 3,720 | 3,774 | +55 | +1.5% | 172,700 |
| 2024/04/19 | 3,738 | 3,753 | 3,695 | 3,719 | -19 | -0.5% | 170,500 |
| 2024/04/18 | 3,745 | 3,791 | 3,714 | 3,738 | +13 | +0.3% | 196,300 |
| 2024/04/17 | 3,800 | 3,800 | 3,708 | 3,725 | -75 | -2% | 164,500 |
| 2024/04/16 | 3,794 | 3,819 | 3,766 | 3,800 | -25 | -0.7% | 200,300 |
| 2024/04/15 | 3,909 | 3,930 | 3,784 | 3,825 | -84 | -2.1% | 304,500 |
| 2024/04/12 | 3,868 | 3,927 | 3,792 | 3,909 | -29 | -0.7% | 311,400 |
| 2024/04/11 | 3,932 | 3,969 | 3,901 | 3,938 | -17 | -0.4% | 162,300 |
| 2024/04/10 | 3,984 | 4,002 | 3,953 | 3,955 | -5 | -0.1% | 128,400 |
| 2024/04/09 | 3,957 | 3,962 | 3,921 | 3,960 | +3 | +0.1% | 135,200 |
| 2024/04/08 | 3,950 | 3,968 | 3,915 | 3,957 | +31 | +0.8% | 102,200 |
| 2024/04/05 | 3,859 | 3,926 | 3,840 | 3,926 | +44 | +1.1% | 150,200 |
| 2024/04/04 | 3,875 | 3,902 | 3,845 | 3,882 | +25 | +0.6% | 123,000 |
| 2024/04/03 | 3,830 | 3,879 | 3,817 | 3,857 | +16 | +0.4% | 139,900 |
| 2024/04/02 | 3,901 | 3,913 | 3,830 | 3,841 | -74 | -1.9% | 145,100 |
| 2024/04/01 | 3,962 | 3,971 | 3,903 | 3,915 | -58 | -1.5% | 175,300 |
| 2024/03/29 | 3,910 | 3,977 | 3,897 | 3,973 | +60 | +1.5% | 151,500 |
| 2024/03/28 | 3,990 | 4,002 | 3,897 | 3,913 | -87 | -2.2% | 155,400 |
| 2024/03/27 | 4,031 | 4,038 | 3,995 | 4,000 | -5 | -0.1% | 118,800 |
| 2024/03/26 | 3,976 | 4,010 | 3,933 | 4,005 | +20 | +0.5% | 135,800 |
| 2024/03/25 | 4,020 | 4,054 | 3,985 | 3,985 | -50 | -1.2% | 145,400 |
| 2024/03/22 | 4,003 | 4,037 | 3,971 | 4,035 | +41 | +1% | 130,200 |
| 2024/03/21 | 4,032 | 4,032 | 3,990 | 3,994 | -11 | -0.3% | 162,100 |
| 2024/03/19 | 3,976 | 4,008 | 3,962 | 4,005 | +16 | +0.4% | 201,100 |
301～
350
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 428,400円 | +5.8% | +1.2% | 2.80% | 13.87倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 144,700円 | -11.0% | +206.6% | 0.00% | 14.37倍 | 3.39倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 参天薬 | 158,600円 | -2.0% | -7.3% | 2.40% | 15.50倍 | 1.84倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ツムラ | 363,500円 | +3.8% | -19.9% | 3.74% | 11.81倍 | 0.91倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 320,600円 | +3.6% | -15.3% | 3.87% | 9.01倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
